Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Eckstein

Showing results (111-120 of 262) with videos related to

Pageof 27
Sort By:
Scientific Reports|September 28, 2018
CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-makingThomas S Worst, Cleo-Aron Weis, Robert Stöhr, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Prognostic Role of mRNA-Expression of Aquaporins (AQP) 3, 4, 7 and 9 in Stage pT1 Non-Muscle-Invasive Bladder CancerJulian Reiß, Sebastian Kälble, Johannes Bründl, et al.
Virchows Archiv : an International Journal of Pathology|March 27, 2026
Nectin-4 expression in vulvar squamous cell carcinomaFrederik A Stuebs, Antje Knöll, Arndt Hartmann, et al.
BJU International|August 19, 2018
FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancerJohannes Breyer, Ralph M Wirtz, Philipp Erben, et al.
Clinical Genitourinary Cancer|March 12, 2018
High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder CarcinomaJohannes Breyer, Ralph M Wirtz, Philipp Erben, et al.
Oral Oncology|June 24, 2022
Systematic classification of confocal laser endomicroscopy for the diagnosis of oral cavity carcinomaMatti Sievert, Nicolai Oetter, Konstantinos Mantsopoulos, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 13, 2020
Variant morphology and random chromosomal integration of BK polyomavirus in posttransplant urothelial carcinomasSimone Bertz, Armin Ensser, Robert Stoehr, et al.
International Journal of Molecular Sciences|June 27, 2024
Prognostic and Predictive Potential of CCL5 Expression in Muscle-Invasive Bladder Cancer PatientsCedric Smolka, Markus Eckstein, Rudolf Jung, et al.
Frontiers in Immunology|July 14, 2023
Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinomaTina Daunke, Silje Beckinger, Sascha Rahn, et al.
Translational Oncology|March 26, 2017
High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder CancerDanijel Sikic, Johannes Breyer, Arndt Hartmann, et al.
Pageof 27

Showing results (111-120 of 262) with videos related to

Sort By:
Pageof 27
Scientific Reports|September 28, 2018
CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-makingThomas S Worst, Cleo-Aron Weis, Robert Stöhr, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Prognostic Role of mRNA-Expression of Aquaporins (AQP) 3, 4, 7 and 9 in Stage pT1 Non-Muscle-Invasive Bladder CancerJulian Reiß, Sebastian Kälble, Johannes Bründl, et al.
Virchows Archiv : an International Journal of Pathology|March 27, 2026
Nectin-4 expression in vulvar squamous cell carcinomaFrederik A Stuebs, Antje Knöll, Arndt Hartmann, et al.
BJU International|August 19, 2018
FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancerJohannes Breyer, Ralph M Wirtz, Philipp Erben, et al.
Clinical Genitourinary Cancer|March 12, 2018
High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder CarcinomaJohannes Breyer, Ralph M Wirtz, Philipp Erben, et al.
Oral Oncology|June 24, 2022
Systematic classification of confocal laser endomicroscopy for the diagnosis of oral cavity carcinomaMatti Sievert, Nicolai Oetter, Konstantinos Mantsopoulos, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 13, 2020
Variant morphology and random chromosomal integration of BK polyomavirus in posttransplant urothelial carcinomasSimone Bertz, Armin Ensser, Robert Stoehr, et al.
International Journal of Molecular Sciences|June 27, 2024
Prognostic and Predictive Potential of CCL5 Expression in Muscle-Invasive Bladder Cancer PatientsCedric Smolka, Markus Eckstein, Rudolf Jung, et al.
Frontiers in Immunology|July 14, 2023
Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinomaTina Daunke, Silje Beckinger, Sascha Rahn, et al.
Translational Oncology|March 26, 2017
High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder CancerDanijel Sikic, Johannes Breyer, Arndt Hartmann, et al.
Pageof 27